TITLE

The 2009-2014 Outlook for Pharmaceutical Preparations for Veterinary Use Excluding Diagnostics in India

AUTHOR(S)
Parker, Philip M.
PUB. DATE
January 2010
SOURCE
Country Outlook Reports;1/22/2010, pN.PAG
SOURCE TYPE
Industry Profile
DOC. TYPE
Article
ABSTRACT
Several charts are presented that depict the 2009-2014 outlook for pharmaceutical preparations for veterinary use in various cities in India, including Faridabad, Chandigarh, and Delhi.
ACCESSION #
58801896

 

Related Articles

  • The 2009-2014 Outlook for Pharmaceutical Preparations for Veterinary Use in India. Parker, Philip M. // Country Outlook Reports;1/22/2010, pN.PAG 

    Several charts are presented that depict the 2009-2014 outlook for pharmaceutical preparations for veterinary use in various cities in India, including Faridabad, Chandigarh, and Delhi.

  • The 2009-2014 Outlook for Veterinary Antibiotic Pharmaceuticals Excluding Penicillins and Tetracyclines in Japan. Parker, Philip M. // Country Outlook Reports;1/13/2010, pN.PAG 

    Several charts on the 2009-2014 outlook for veterinary antibiotic pharmaceuticals excluding penicillins and tetracyclines, in several cities of Japan, including Nagasaki, Tokyo and Osaka, are presented.

  • Nausea, vomiting: First treat the underlying cause. Hoskins, Johnny D. // DVM: The Newsmagazine of Veterinary Medicine;Aug2008, Vol. 39 Issue 8, p10S 

    The article presents question and answer about anti-emetic and prokinetic drugs.

  • Using the VMD's product information database. Eckford, Suzanne; Davis, Giles // Veterinary Record: Journal of the British Veterinary Association;10/31/2015, Vol. 177 Issue 17, p448 

    A letter to the editor is presented discussing the issue of making changes to the Summary of Product Characteristics (SPC) of veterinary medicinal products in Great Britain.

  • Correction.  // Veterinary Record: Journal of the British Veterinary Association;11/28/2015, Vol. 177 Issue 21, p533 

    A correction to the report "Working together on the responsible use of medicines" in the November 21, 2015 issue of "Veterinary Record" journal is presented.

  • Generic medical products: A PRIMER.  // Firstline;Aug2011, Vol. 7 Issue 8, p20 

    The article discusses the emergence of veterinary generic drugs. Reasons why veterinarians offer generics are lower cost and better compliance. It says that 94% of veterinary practices in the U.S. prescribe generics. discusses flea and tick control, and presents veterinarians' opinions on the...

  • Metabolism of 14C-labelled and non-labelled sulfadiazine after administration to pigs. Lamshöft, Marc; Sukul, Premasis; Zühlke, Sebastian; Spiteller, Michael // Analytical & Bioanalytical Chemistry;Aug2007, Vol. 388 Issue 8, p1733 

    The behaviour of sulfadiazine (SDZ) and its metabolites was investigated by administering the 14C-labelled veterinary drug to fattening pigs. The excretion kinetics were determined after daily collection of manure. Two known metabolites, N-acetylsulfadiazine and 4-hydroxysulfadiazine, and two...

  • Opinion: Challenges and opportunities in animal drug development: a regulatory perspective. Lathers, Claire M. // Nature Reviews Drug Discovery;Nov2003, Vol. 2 Issue 11, p1 

    Veterinary drugs are important in maintaining the health and productivity of agricultural animals, and the health of companion animals. Although there are many parallels between the development of animal drugs and human drugs, there are also important differences. This article focuses on some...

  • dvm TABLE 1.  // DVM: The Newsmagazine of Veterinary Medicine;Dec2009, Vol. 40 Issue 12, p18 

    A chart is presented depicting Fort Dodge Animal Health Ltd. products retained by Pfizer Animal Health and Fort Dodge equine products retained by Pfizer.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics